Chewy Shares Surge On Wednesday: What You Need To Know
Chewy Shares Surge On Wednesday: What You Need To Know
Chewy, Inc. (NYSE:CHWY) shares are trading higher in response to Petco Health and Wellness Inc's (NASDAQ:WOOF) second-quarter financial results. Petco's earnings report, which showed quarterly sales of $1.52 billion, met analyst estimates, although the company missed its earnings target with losses of nine cents per share compared to the expected 2 cents.
Chewy, Inc.（紐約證券交易所代碼：CHWY）股價上漲，這是對Petco Health and Wellness Inc.（納斯達克股票代碼：WOOF）第二季度財務業績的回應。Petco的收益報告顯示季度銷售額爲15.2億美元，符合分析師的預期，儘管該公司未實現其收益目標，每股虧損9美分，而預期爲2美分。
What To Know: Petco's consumables and services segments showed growth, with a 1.5% and 3.1% year-over-year increase, respectively, but these gains were offset by a 4.7% decline in its supplies and companion animal business. Despite these mixed results, the market responded positively, pushing Petco stock up 7.72% during Tuesday's session, and Chewy appeared to benefit from this momentum as a peer in the pet care sector.
須知：Petco的消費品和服務板塊顯示出增長，分別同比增長1.5％和3.1％，但這些增長被其供應和伴侶動物業務下降4.7％所抵消。儘管業績喜憂參半，但市場反應積極，推動Petco股價在週二的交易中上漲了7.72％，作爲寵物護理領域的同行，Chewy似乎受益於這一勢頭。
The surge in Petco's stock continued into Wednesday, fueled by an unexpected catalyst: the involvement of Keith Gill, known as "Roaring Kitty." By midday, the stock had soared nearly 35% after Gill posted a cryptic message on Reddit, igniting excitement in the meme stock community.
Petco股票的飆升一直持續到週三，這得益於一個意想不到的催化劑：被稱爲 「Roaring Kitty」 的基思·吉爾的參與。截至中午，該股已飆升近35％，此前吉爾在Reddit上發佈了一條神祕的消息，引發了模因股票界的興奮。
What Else: Roaring Kitty, also famously associated with the GameStop trading frenzy, posted a cryptic image from "Toy Story," speculated to reference Chewy stock, in which Keith Gill previously held a large position.
還有什麼：同樣與GameStop交易狂潮相關的Roaring Kitty發佈了一張來自《玩具總動員》的神祕圖片，據推測該圖片是指Chewy股票，基思·吉爾此前在該股票中持有大量頭寸。
CHWY Price Action: Chewy shares closed 8.12% higher at $30.24 on Wednesday, according to Benzinga pro.
CHWY價格走勢：據Benzinga專業人士稱，Chewy股價週三收盤上漲8.12％，至30.24美元。
- UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
- UnitedHealth 緊隨競爭對手，用低成本生物仿製藥取代 Humira
Photo via Shutterstock.
照片來自 Shutterstock。